Baculovirus-mediated transgene expression in both mammalian and insect cells
US8598136B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2011 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Oct 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2999/007
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to a method for expressing a gene in a cell. The method includes introducing into a cell an agent that inhibits one or both of miRNA pathway and antiviral defense pathway; and a baculovirus that contains a nucleic acid molecule including a gene operably linked to a promoter; and expressing the gene in the cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.